Leronlimab still appears to be most effective in t
Post# of 148297
(Total Views: 712)
Posted On: 10/28/2020 5:49:15 PM
Re: Riztheinvestor #63594
Leronlimab still appears to be most effective in the S/C population. The limited data in this PR doesn’t list a reduction in hospitalizations, ventilations, or mortality in relation to the administration of their medication. The PR says hospital visits were reduced. So, IMO, based on the PR, leronlimab still serves a purpose in the S/C population.
I’ll say this thought, Regeneron’s cocktail appears to be a game changer when compared to remdesevir.
I’ll say this thought, Regeneron’s cocktail appears to be a game changer when compared to remdesevir.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼